Posted in | News | Copper | Molybdenum

Burnstone Ventures Starts Drilling at Tomichi Porphyry Project

Burnstone Ventures has declared that the 2012 drilling campaign has been started at the Tomichi porphyry copper-molybdenum project, located in south-central Colorado.

In addition, the 2012 campaign will outline and extend the high-grade shallow and popular mineralization area. The company will compile the samples for metallurgical testing. The results received from the 2012 metallurgical testing and drill campaign are significant phases towards the conclusion of a 43-101 compliant economic assessment.

According to Burnstone Ventures’ CEO and President, Doug Fulcher, the company is delighted to move the drilling rig to the property. This is the initial drilling program of the company at the Tomichi project. Burnstone is expecting this program’s results to increase the resource estimation and to improve the overall economy of the deposit. ALS Labs will be contracted to perform the metallurgical work and Burnstone will discuss with the engineering companies to complete an initial development study and associated economic model.

Recently, Burnstone again logged and assayed 22 historic holes out of 26. The recent assay results together with previous assays were specifically utilized to calculate the project’s initially published NI-43-101 mineral resource.

Geosim Services’ Ronald Simpson completed the resource calculation. The resource includes 2.5 Blbs of copper, 552 Mlbs of molybdenum, 30 Moz of silver, 320,000 oz of gold, 124,362 kg of Rhenium, or 5.6 Blbs of copper equivalence in the Base Case scenario.

Burnstone has an option to get a 100% interest in the Tomichi porphyry project situated in south-central Colorado. This project lies in the Colorado mineral belt and was worked initially by Climax Molybdenum and recently by Molycorp. Due to fractured land ownership, work has not been conducted since the drilling campaign in 1982.

Joel Scanlon

Written by

Joel Scanlon

Joel relocated to Australia in 1995 from the United Kingdom and spent five years working in the mining industry as an exploration geotechnician. His role involved utilizing GIS mapping and CAD software. Upon transitioning to the North Coast of NSW, Australia, Joel embarked on a career as a graphic designer at a well-known consultancy firm. Subsequently, he established a successful web services business catering to companies across the eastern seaboard of Australia. It was during this time that he conceived and launched News-Medical.Net. Joel has been an integral part of AZoNetwork since its inception in 2000. Joel possesses a keen interest in exploring the boundaries of technology, comprehending its potential impact on society, and actively engaging with AI-driven solutions and advancements.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Scanlon, Joel. (2019, February 18). Burnstone Ventures Starts Drilling at Tomichi Porphyry Project. AZoMining. Retrieved on November 21, 2024 from https://www.azomining.com/News.aspx?newsID=7183.

  • MLA

    Scanlon, Joel. "Burnstone Ventures Starts Drilling at Tomichi Porphyry Project". AZoMining. 21 November 2024. <https://www.azomining.com/News.aspx?newsID=7183>.

  • Chicago

    Scanlon, Joel. "Burnstone Ventures Starts Drilling at Tomichi Porphyry Project". AZoMining. https://www.azomining.com/News.aspx?newsID=7183. (accessed November 21, 2024).

  • Harvard

    Scanlon, Joel. 2019. Burnstone Ventures Starts Drilling at Tomichi Porphyry Project. AZoMining, viewed 21 November 2024, https://www.azomining.com/News.aspx?newsID=7183.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.